Drugs / green tea polyphenols
green tea polyphenols
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT01239511 | Nov 2010 → Apr 2012 | intermediate coronary syndrome | Sinphar Pharmaceutical Co., Ltd | Completed | No outcome recorded |
| Phase 2 | NCT00461942 | Apr 2006 → Mar 2009 | Parkinson disease | Xuanwu Hospital, Beijing | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00625391 Comparator | Feb 2008 → Aug 2009 | osteoporosis | Texas Tech University Health Sciences Center | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | green tea polyphenols | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01239511 ↗ |
| Known as | Green Tea Polyphenol | “The purpose of this study is to determine whether Green Tea Polyphenol, an extraction from Green Tea is effective and safe in the treatment of De Novo Parkinson's disease...” NCT00461942 ↗ |
| Known as | GTP | “Postmenopausal women with osteopenia received green tea polyphenols (GTP) supplement and/or Tai Chi exercise for 6 months.” PMID 21766228 ↗ Jul 2011 |
| Known as | STA-2 | “green tea polyphenols (STA-2)” NCT01239511 ↗ |
| Route | Oral | “2 capsules t.i.d., after meal” NCT01239511 ↗ |